{"name":"EMD Serono","slug":"emd-serono","ticker":"","exchange":"","domain":"","description":"Merck Serono is a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of Merck focused on biopharmaceuticals.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"immunology","drugs":[{"name":"Antagon ™","genericName":"Antagon ™","slug":"antagon","indication":"Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (ART)","status":"marketed"},{"name":"Clomiphene Citrate 50 mg","genericName":"Clomiphene Citrate 50 mg","slug":"clomiphene-citrate-50-mg","indication":"Other","status":"phase_2"},{"name":"Luveris® 25 IU","genericName":"Luveris® 25 IU","slug":"luveris-25-iu","indication":"Other","status":"marketed"},{"name":"Luveris® 75 IU","genericName":"Luveris® 75 IU","slug":"luveris-75-iu","indication":"Other","status":"marketed"},{"name":"Rebif®","genericName":"Rebif®","slug":"rebif","indication":"Other","status":"marketed"},{"name":"Saizen®","genericName":"Saizen®","slug":"saizen","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"neuroscience","drugs":[{"name":"Interferon-beta-1a FBS-free/HSA-free","genericName":"Interferon-beta-1a FBS-free/HSA-free","slug":"interferon-beta-1a-fbs-free-hsa-free","indication":"Multiple sclerosis (relapsing-remitting form)","status":"phase_3"},{"name":"Rebif New Formulation Non Titrated","genericName":"Rebif New Formulation Non Titrated","slug":"rebif-new-formulation-non-titrated","indication":"Relapsing forms of multiple sclerosis","status":"phase_3"},{"name":"Rebif New Formulation Titrated","genericName":"Rebif New Formulation Titrated","slug":"rebif-new-formulation-titrated","indication":"Relapsing forms of multiple sclerosis","status":"phase_3"},{"name":"Ribavirin plus Interferon-beta-1a","genericName":"Ribavirin plus Interferon-beta-1a","slug":"ribavirin-plus-interferon-beta-1a","indication":"Hepatitis C virus infection (in combination regimens)","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Atacicept: with loading dose","genericName":"Atacicept: with loading dose","slug":"atacicept-with-loading-dose","indication":"Rheumatoid arthritis","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"EMD 72000","genericName":"EMD 72000","slug":"emd-72000","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Serostim®","genericName":"Serostim®","slug":"serostim","indication":"HIV-associated wasting or cachexia in patients with HIV infection and low body weight","status":"marketed"}]}],"pipeline":[{"name":"Atacicept: with loading dose","genericName":"Atacicept: with loading dose","slug":"atacicept-with-loading-dose","phase":"phase_2","mechanism":"CD28/B7 costimulation blockade","indications":["Rheumatoid arthritis"],"catalyst":""},{"name":"Antagon ™","genericName":"Antagon ™","slug":"antagon","phase":"marketed","mechanism":"Antagon is a gonadotropin-releasing hormone (GnRH) antagonist that rapidly suppresses luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to prevent premature ovulation during assisted reproductive technology.","indications":["Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (ART)"],"catalyst":""},{"name":"Clomiphene Citrate 50 mg","genericName":"Clomiphene Citrate 50 mg","slug":"clomiphene-citrate-50-mg","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"EMD 72000","genericName":"EMD 72000","slug":"emd-72000","phase":"phase_2","mechanism":"EMD 72000 is a monoclonal antibody targeting PD-L1.","indications":["Non-small cell lung cancer, PD-L1 positive","Head and neck squamous cell carcinoma"],"catalyst":""},{"name":"Interferon-beta-1a FBS-free/HSA-free","genericName":"Interferon-beta-1a FBS-free/HSA-free","slug":"interferon-beta-1a-fbs-free-hsa-free","phase":"phase_3","mechanism":"Interferon-beta-1a activates interferon-alpha/beta receptors on immune cells to enhance antiviral and immunomodulatory responses.","indications":["Multiple sclerosis (relapsing-remitting form)","Relapsing forms of multiple sclerosis"],"catalyst":""},{"name":"Luveris® 25 IU","genericName":"Luveris® 25 IU","slug":"luveris-25-iu","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Luveris® 75 IU","genericName":"Luveris® 75 IU","slug":"luveris-75-iu","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Rebif New Formulation Non Titrated","genericName":"Rebif New Formulation Non Titrated","slug":"rebif-new-formulation-non-titrated","phase":"phase_3","mechanism":"Rebif New Formulation Non Titrated is an interferon beta-1a formulation used to treat multiple sclerosis.","indications":["Relapsing forms of multiple sclerosis"],"catalyst":""},{"name":"Rebif New Formulation Titrated","genericName":"Rebif New Formulation Titrated","slug":"rebif-new-formulation-titrated","phase":"phase_3","mechanism":"Rebif New Formulation Titrated is an interferon beta-1a formulation used to treat multiple sclerosis.","indications":["Relapsing forms of multiple sclerosis"],"catalyst":""},{"name":"Rebif®","genericName":"Rebif®","slug":"rebif","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ribavirin plus Interferon-beta-1a","genericName":"Ribavirin plus Interferon-beta-1a","slug":"ribavirin-plus-interferon-beta-1a","phase":"phase_3","mechanism":"Ribavirin inhibits viral RNA synthesis while interferon-beta-1a activates innate immune responses to suppress viral replication and enhance antiviral immunity.","indications":["Hepatitis C virus infection (in combination regimens)","Multiple sclerosis (interferon-beta-1a component)"],"catalyst":""},{"name":"Saizen®","genericName":"Saizen®","slug":"saizen","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Serostim®","genericName":"Serostim®","slug":"serostim","phase":"marketed","mechanism":"Serostim is a recombinant human growth hormone that stimulates anabolic processes and increases lean body mass in patients with HIV-associated wasting.","indications":["HIV-associated wasting or cachexia in patients with HIV infection and low body weight"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNUlZhVW9NRVp0bUREdDhRTWFIZ2tjQTdHNkVIYmFrUEhFWlcwb01PQkNoeUpiZ1dqMnA1Z1B0Ykh3X1JGelZxOVQ5UEFtQ0VPVWJ5TlRkbWNpZmo5Z2NGOURlLTR0T0VLUTJYNXM4anRfbTFzaEU4dUgydGozYmxZbndGdkpKVk15ZEIwdllKeHRxUzZPWnRPUTkwMlZ1Z1BvUjBWcXhrSlNublE?oc=5","date":"2025-11-13","type":"pipeline","source":"Mintz","summary":"Pharmaceutical Policy in Motion: Updates on the Trump Administration’s Drug Pricing Initiatives - Mintz","headline":"Pharmaceutical Policy in Motion: Updates on the Trump Administration’s Drug Pricing Initiatives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQMXlRYWRFM2swd1JfUmFWVjkyV0N1LWxIR3B0ZWkxZFljVFFQN2U1VkpfUEJiX3FWc3BKeGxyZFNxeUtZU2tfWTJWQzZhMGFnMzB1cHRmVnZ2UHB1cTBXZWR4NlNYZ1YzQ29rNG00Y3JWMTQ0ekw4THZjeDc3ZXR3QW9rbmUwaDZMSk9iWDY4QnRsN2JkbEpSbnQ3MzAxTm9kZHhUME9YUUZnNmZ2eVFFWXFtYTFqQQ?oc=5","date":"2025-10-17","type":"deal","source":"Fierce Pharma","summary":"Merck KGaA's EMD Serono strikes MFN deal in Trump's fertility treatment pricing push - Fierce Pharma","headline":"Merck KGaA's EMD Serono strikes MFN deal in Trump's fertility treatment pricing push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOelhwTXlwTERUVHhDdm5JTU45ZVRMYXRSNEhxWm1VY2NrQ2FtSElKWldBLUpEUlVoWHdjbUFPRjlRWUtwSXBqS3RmVVNWdEFwYkU3RUJrSDVQRHc2bFh5bXhhRThRM1hhVnp6XzRtRldtbFFrZkl4cU1iUHNhcXp1V2dfeXdjemFDMURKX0R4N3VLc2c4ckxBSzFaZExxc0JrOS1tbEhPNEszS0dMVGhMWg?oc=5","date":"2025-10-17","type":"pipeline","source":"BioSpace","summary":"In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program - BioSpace","headline":"In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTFBVazJJZWxkYkhKbjVSTVFDTTdiVExZVHowS2F5YS1lU1JXNkV0Q2FGa1QyRDAwcjlIV2Z4cTEySnl0U0twbllHVXJlQWFLajdlSjZicmVIOEtvYnRRVDZINGt1MFg2UnRvd2FwQzZrRU5KWlU?oc=5","date":"2025-10-17","type":"deal","source":"pharmaphorum","summary":"Merck joins the Trump MFN gang with IVF deal - pharmaphorum","headline":"Merck joins the Trump MFN gang with IVF deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNRV9wVG1jb292U1hHZnNyOEVrWWlvd0NVOUNMVmtqU0VhX2FjR3RMaVhzVV91U01CdFhmOVpMWDZaZnN2Q0JaSHN1cUpMTFRaR3lYVUhnVkVELVZJVlFkZldFbnQ0bVBhVU41SmxuMzE1ODNqTmEzQmpfOU1kWFVzWjRaZWJvejJtSHllWmw0aEdRQmlmODFhQ1RtWTI?oc=5","date":"2025-10-17","type":"pipeline","source":"European Biotechnology Magazine","summary":"Merck KGaA reduces US prices for IVF drugs by 84% - European Biotechnology Magazine","headline":"Merck KGaA reduces US prices for IVF drugs by 84%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOTkdQejFEOEkxVGtjbkxnNlR2cGxqdWpxRVJpekRwVXFfaUJrOXpUTFRHVTdjT0pZUkNYTEprQ1IzZ29vODdNQVF2ZlRSVGd1QnJyUWdnS1NhTFhycS1YbHJjQzBKTHV3eGZjSS1xRWM1UVV4VTJaS1piaFIwN213UllLSU1HRFRhMEY4RF9oVTF1Q3NlY3h3bDBNbzBneXZ3MjZmNHc0ZXhxMjk5dWhBa1FTQWRveTRNNmdfNDROREdyNEFDM1ZEUHJ6eXNYbHJTWV9FNVp3?oc=5","date":"2025-10-16","type":"pipeline","source":"EMD Serono","summary":"2025-10-16 Agreement with U.S. Government to Expand Access to IVF Therapies - EMD Serono","headline":"2025-10-16 Agreement with U.S. Government to Expand Access to IVF Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPeDYwLVNGeTlBSVJwLUJ4emRORmpOSVJuVkFLQ1JYWkRsNmxnSC1qLTFOM0xaOXhuSk1QVmh3VTlLMmJlMkJNZjlwMXM2Um5LZW04VGo4NnNLTndhY1l6d3Y0RFl6MjNWZnlET3BubmstSFd3TlR1TXA0OGF4U0hoZlhXdlBWb1FDY296V1RjNng?oc=5","date":"2025-10-16","type":"deal","source":"statnews.com","summary":"Trump announces plan to expand fertility treatment coverage alongside latest pharma deal - statnews.com","headline":"Trump announces plan to expand fertility treatment coverage alongside latest pharma deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQbkhPOHBPQmVpZjBOLV91UDhnUlREVXN5UzVQWTlja0NtTkpqSk4tWm1VRTYzR3NJa2Z4a3dfTjF3Vlc1Nk1rTUFvR2NTZENUT0ZmLWZOZy16YmpReGNEU2V1SkxWeEEwZ0hYV0FYdmlmOEppeGJKeEs1cFVFTy1tRk11ell2aGF2X2x1ZkFVQURxbEZXdWU2SW5udmlYQdIBowFBVV95cUxNUGYyaW1YOVZ6cEhfUjFDamFjekdnTnl6SkR1ck9BblZXTWJwdlV6NFdHblFCR1lvb29ZMXZWOUhnTXlDcldtUzZhR1dkYWJLU3Z5ODJvU2xON3p6VDkyc3ZyRlJ6M1E5Y05tVWFHYnVqYWRsMnhRUlJyeERJajU2V3NMRDZraVhQdkF3WUFrTEszMFFHNGFNWU1NZ095X2NNcVZR?oc=5","date":"2025-10-16","type":"deal","source":"PBS","summary":"WATCH: Trump announces deal with EMD Serono to lower fertility drug prices - PBS","headline":"WATCH: Trump announces deal with EMD Serono to lower fertility drug prices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5QTzFoZlc0djVfdUlfdUZzVzNsZEdpQmx5MXpKVGdlXzVMSm4ya0xLRElEZzFNQ2VONzJrenQtd1J6LVJTTTVOaEsxQzVlWEU3bVZF?oc=5","date":"2025-10-16","type":"pipeline","source":"FirstWord Pharma","summary":"TrumpRx welcomes Merck KGaA, one of nine to receive new priority voucher - FirstWord Pharma","headline":"TrumpRx welcomes Merck KGaA, one of nine to receive new priority voucher","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPT0NlUlI1emxkY3BBYzZaSzY4TFdscGNIZm1HRnJ4RmJwNjRZQU9JV0hINUhIZEpqNTNialVFbHRTSWhhdmQ2X3dWUFV0NHI5aGlUbnBuUmhCVnBxUmNwSzlpdnNVRE15WmhsTS01Rm1VcTlSeUhWa1I4c09VV3ZCcklURHpoWE4xR2ZYS3lUVjRkZU1wSWFTVkFINWh3RkwwSHNuR1Q0aUN3QdIBrwFBVV95cUxQN3JTR3hsZkJoRnVDZ01BN0lmVTc0eDNJNVE3VW4wQko0bk5CeTZfbjdWc1BRODB6bzNselNqbXp1dHFEVi1MdHpHZFJlWDJwdXRKRjdQYlRNNVBrTGZFMDQ1bmN1MElaa3ZWbWV1aUVyb3JPUkFLTFlOTFloWVJ1ZUZ6dWd3YVBMRGNOblNndG5lV083b09OWFItVGQ0Z0lWT0NkX05MOS1Vc0htSG9z?oc=5","date":"2025-10-16","type":"deal","source":"foxnews.com","summary":"Trump rolls out plan to slash IVF costs for American families through new pharma partnership - foxnews.com","headline":"Trump rolls out plan to slash IVF costs for American families through new pharma partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQWHFnSXpubVdqeGpGUTJxbXUtMWgtc04wV3lRSlpvUXk2UnY0Tk5XZ043NEItM3haY1JnY3hIeGFwTTFWQl8tV1VXUFRNT1JxNGRscFo3U2Q5N2d2cnJHWUFiaEU5bnRKQm5JZFhmZ2I2R1FDQzlpeWxrQTRkRGprS1pPSmZablQzTHdHN3FyM3QwczlNcjlqYlpOcjZWeEJmYmc?oc=5","date":"2025-10-16","type":"regulatory","source":"endpoints.news","summary":"White House makes new ‘most favored nation’ deal, shares updates on FDA vouchers, GLP-1 negotiations - endpoints.news","headline":"White House makes new ‘most favored nation’ deal, shares updates on FDA vouchers, GLP-1 negotiations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNaWt1OWZZS1VmUUVJRWt3djlzcnAxcV94eGlGWENYbWRrMUp4amtnUUkxUHBqWmYyQ0pZMHo2RlVFZl9tVUdoSnRKY2NhTnhDM0xIXzJac1JzVUloOEZ5TDZrVVA1SzdVbmlNZkdZbGhXcFNYVGRiVk1fczBiUEQ0VnJ3RGFJblVZ?oc=5","date":"2025-08-15","type":"pipeline","source":"Pharma Voice","summary":"Merck KGaA ventures into new territory in the US - Pharma Voice","headline":"Merck KGaA ventures into new territory in the US","sentiment":"neutral"}],"patents":[],"drugCount":13,"phaseCounts":{"phase_2":3,"marketed":6,"phase_3":4},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}